VEGFA and neoplasm: It was reported that VEGF inhibition reduces TAMs and Tregs in the tumor microenvironment, decreases TGF-β and IL-10 expression, decreases the expression of T-cell exhaustion markers, such as PD-1 and TIM-3, and increases the release of immunostimulatory cytokines [91].